1 |
Athanassiou, Z., Dias, R. L., Moehle, K., Dobson, N., Varani, G. and Robinson, J. A. (2004) Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affi nity and selectivity for viral TAR RNA regulatory elements. J. Am. Chem. Soc. 126, 6906-6913.
DOI
ScienceOn
|
2 |
Athanassiou, Z., Patora, K., Dias, R. L., Moehle, K., Robinson, J. A. and Varani, G. (2007) Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodefi ciency virus. Biochemistry. 46, 741-751.
DOI
ScienceOn
|
3 |
Bu, X., Wu, X., Xie, G. and Guo, Z. (2002) Synthesis of tyrocidine A and its analogues by spontaneous cyclization in aqueous solution. Org. Lett. 4, 2893-2895.
DOI
ScienceOn
|
4 |
Colgrave, M. L., Korsinczky, M. J., Clark, R. J., Foley, F. and Craik, D. J. (2010) Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs. Biopolymers. 94, 665-672.
DOI
ScienceOn
|
5 |
Dubos, R. J. and Cattaneo, C. (1939) Studies on a bactericidal agent extracted from a soil bacillus : Iii. preparation and activity of a protein-free fraction. J. Exp. Med. 70, 249-256.
DOI
|
6 |
Eckert, K., Schwarz, H., Tomer, K. B. and Gross, M. L. (1985). Tandem mass spectrometry methodology for the sequence determination of cyclic peptides. J. Am. Chem. Soc. 107, 6765-6769.
DOI
|
7 |
Edman, P. (1959) Chemistry of amino acids and peptides. Annu. Rev. Biochem. 28, 69-96.
DOI
ScienceOn
|
8 |
Furka, A., Sebestyen, F., Asgedom, M. and Dibo, G. (1991) General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein. Res. 37, 487-493.
|
9 |
Gehlsen, K. R., Argraves, W. S., Pierschbacher, M. D. and Ruoslahti, E. (1988) Inhibition of in vitro tumor cell invasion by Arg-Gly-Aspcontaining synthetic peptides. J. Cell. Biol. 106, 925-930.
DOI
ScienceOn
|
10 |
Giroux, R. (2005) Cyclosporine. Chem. Eng. News. 83, 56.
DOI
|
11 |
Gurrath, M., Müller, G., Kessler, H., Aumailley, M. and Timpl, R. (1992) Conformation/activity studies of rationally designed potent antiadhesive RGD peptides. Eur. J. Biochem. 210, 911-921.
DOI
ScienceOn
|
12 |
Hayashi, R., Tanoue, K., Durell, S. R., Chatterjee, D. K., Jenkins, L. M., Appella, D. H. and Appella, E. (2011) Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1). Biochemistry. 50, 4537-4549.
DOI
ScienceOn
|
13 |
Hayouka, Z., Hurevich, M., Levin, A., Benyamini, H., Iosub, A., Maes, M., Shalev, D. E., Loyter, A., Gilon, C. and Friedler, A. (2010) Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Bioorg. Med. Chem. 18, 8388-8395.
DOI
ScienceOn
|
14 |
Hodgkin, D. C. and Oughton, B. M. (1957) Possible molecular models for gramicidin S and their relationship to present ideas of protein structure. Biochem. J. 65, 752-756.
|
15 |
Horswill, A. R., Savinov, S. N. and Benkovic, S. J. (2004) A systematic method for identifying small-molecule modulators of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 101, 15591-15596.
DOI
ScienceOn
|
16 |
Horton, D. A., Bourne, G. T. and Smythe, M. L. (2002) Exploring privileged structures: the combinatorial synthesis of cyclic peptides. J. Comput. Aided. Mol. Des. 16, 415-430.
DOI
ScienceOn
|
17 |
Hotchkiss, R. D. (1941) The chemical nature of gramicidin and tyrocidine. J. Biol. Chem. 141, 171-185.
|
18 |
Hotchkiss, R. D. and Dubos, R. J. (1941) The isolation of bactericidal substances from cultures of Bacillus brevis. J. Biol. Chem. 141, 155-162.
|
19 |
Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T. and Cuervo, J. H. (1991) Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature. 354, 84-86.
DOI
ScienceOn
|
20 |
Hull, S. E., Karlsson, R., Main, P., Woolfson, M. M. and Dodson, E. J. (1978) The crystal structure of a hydrated gramicidin S-urea complex. Nature. 275, 206-207.
DOI
ScienceOn
|
21 |
Hummel, G., Reineke, U. and Reimer, U. (2006) Translating peptides into small molecules. Mol. Biosyst. 2, 499-508.
DOI
ScienceOn
|
22 |
Humphries, M. J., Olden, K. and Yamada, K. M. (1986) A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science. 233, 467-470.
DOI
|
23 |
Joo, S. H., Xiao, Q., Ling, Y., Gopishetty, B. and Pei, D. (2006) Highthroughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry. J. Am. Chem. Soc. 128, 13000-13009.
DOI
ScienceOn
|
24 |
Kohli, R. M., Walsh, C. T. and Burkart, M. D. (2002) Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature 418, 658-661.
DOI
ScienceOn
|
25 |
Koivunen, E., Gay, D. A. and Ruoslahti, E. (1993) Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J. Biol. Chem. 268, 20205-20210.
|
26 |
Kwon, Y. U. and Kodadek, T. (2007) Quantitative comparison of the relative cell permeability of cyclic and linear peptides. Chem. Biol. 14, 671-677.
DOI
ScienceOn
|
27 |
Kwon, Y. U. and Kodadek, T. (2008) Encoded combinatorial libraries for the construction of cyclic peptoid microarrays. Chem. Commun. (Camb). 44, 5704-5706.
|
28 |
Lalonde, M. S., Lobritz, M. A., Ratcliff, A., Chamanian, M., Athanassiou, Z., Tyagi, M., Wong, J., Robinson, J. A., Karn, J., Varani, G. and Arts, E. J. (2011) Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tattransactivating response element (TAR) RNA. PLoS. Pathog. 7, e1002038.
DOI
|
29 |
Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M. and Knapp, R. J. (1991) A new type of synthetic peptide library for identifying ligand-binding activity. Nature. 354, 82-84.
DOI
ScienceOn
|
30 |
Liu, T., Joo, S. H., Voorhees, J. L., Brooks, C. L. and Pei, D. (2009) Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor. Bioorg. Med. Chem. 17, 1026-1033.
DOI
ScienceOn
|
31 |
Liu, T., Liu, Y., Kao, H. Y. and Pei, D. (2010) Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1. J. Med. Chem. 53, 2494-2501.
DOI
ScienceOn
|
32 |
Loffet, A. (2002) Peptides as drugs: is there a market? J. Pept. Sci. 8, 1-7.
DOI
ScienceOn
|
33 |
Mas-Moruno, C., Rechenmacher, F. and Kessler, H. (2010) Cilengitide: the fi rst anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer. Agents. Med. Chem. 10, 753-768.
DOI
ScienceOn
|
34 |
Matsuzaki, K. (1999) Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta. 1462, 1-10.
DOI
ScienceOn
|
35 |
Millward, S. W., Fiacco, S., Austin, R. J. and Roberts, R. W. (2007) Design of cyclic peptides that bind protein surfaces with antibody-like affi nity. ACS. Chem. Biol. 2, 625-634.
DOI
ScienceOn
|
36 |
Millward, S. W., Takahashi, T. T. and Roberts, R. W. (2005) A general route for post-translational cyclization of mRNA display libraries. J. Am. Chem. Soc. 127, 14142-14143.
DOI
ScienceOn
|
37 |
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W. and Cheresh, D. A. (2008) Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc. Natl. Acad. Sci. USA 105, 9343-9348.
DOI
ScienceOn
|
38 |
Naumann, T. A., Tavassoli, A. and Benkovic, S. J. (2008) Genetic selection of cyclic peptide Dam methyltransferase inhibitors. Chembiochem. 9, 194-197.
DOI
ScienceOn
|
39 |
Ngoka, L. C. and Gross, M. L. (1999) Multistep tandem mass spectrometry for sequencing cyclic peptides in an ion-trap mass spectrometer. J. Am. Soc. Mass. Spectrom. 10, 732-746.
DOI
ScienceOn
|
40 |
Noiri, E., Gailit, J., Sheth, D., Magazine, H., Gurrath, M., Muller, G., Kessler, H. and Goligorsky, M. S. (1994) Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney. Int. 46, 1050-1058.
DOI
ScienceOn
|
41 |
O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A. and DeGrado, W. F. (1992) Identifi cation of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins. 14, 509-515.
DOI
ScienceOn
|
42 |
Park, B. W., Zhang, H. T., Wu, C., Berezov, A., Zhang, X., Dua, R., Wang, Q., Kao, G., O'Rourke, D. M., Greene, M. I. and Murali, R. (2000) Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo. Nat. Biotechnol. 18, 194-198.
DOI
ScienceOn
|
43 |
Perler, F. B. (2005) Protein splicing mechanisms and applications. IUBMB. Life. 57, 469-476.
DOI
ScienceOn
|
44 |
Perler, F. B, Davis, E. O., Dean, G. E., Gimble, F. S., Jack, W. E., Neff, N., Noren, C. J., Thorner, J. and Belfort, M. (1994) Protein splicing elements: inteins and exteins--a defi nition of terms and recommended nomenclature. Nucleic. Acids. Res. 22, 1125-1127.
DOI
ScienceOn
|
45 |
Qin, C., Bu, X., Zhong, X., Ng, N. L. and Guo, Z. (2004) Optimization of antibacterial cyclic decapeptides. J. Comb. Chem. 6, 398-406.
DOI
ScienceOn
|
46 |
Qin, C., Zhong, X., Bu, X., Ng, N. L. and Guo, Z. (2003) Dissociation of antibacterial and hemolytic activities of an amphipathic peptide antibiotic. J. Med. Chem. 46, 4830-4833.
DOI
ScienceOn
|
47 |
Redman, J. E., Wilcoxen, K. M. and Ghadiri, M. R. (2003) Automated mass spectrometric sequence determination of cyclic peptide library members. J. Comb. Chem. 5, 33-40.
DOI
ScienceOn
|
48 |
Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P. and Lokey, R. S. (2006) Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers. J. Am. Chem. Soc. 128, 2510-2511.
DOI
ScienceOn
|
49 |
Roberts, R. W. and Szostak, J. W. (1997) RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA 94, 12297-12302.
DOI
ScienceOn
|
50 |
Schilling, B., Wang, W., McMurray, J.S. and Medzihradszky, K.F. (1999) Fragmentation and sequencing of cyclic peptides by matrixassisted laser desorption/ionization post-source decay mass spectrometry. Rapid. Commun. Mass. Spectrom. 13, 2174-2179.
DOI
ScienceOn
|
51 |
Scott, C. P., Abel-Santos, E., Wall, M., Wahnon, D. C. and Benkovic, S. J. (1999) Production of cyclic peptides and proteins in vivo. Proc. Natl. Acad. Sci. USA 96, 13638-13643.
DOI
ScienceOn
|
52 |
Siegel, M. M., Huang, J., Lin, B., Tsao, R. and Edmonds, C. G. (1994) Structures of bacitracin A and isolated congeners: sequencing of cyclic peptides with blocked linear side chains by electrospray ionization mass spectrometry. Biol. Mass. Spectrom. 23, 186-204.
DOI
ScienceOn
|
53 |
Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228, 1315-1317.
DOI
|
54 |
Stauch, B., Simon, B., Basile, T., Schneider, G., Malek, N. P., Kalesse, M. and Carlomagno, T. (2010) Elucidation of the structure and intermolecular interactions of a reversible cyclic-peptide inhibitor of the proteasome by NMR spectroscopy and molecular modeling. Angew. Chem. Int. Ed. Engl. 49, 3934-3938.
DOI
ScienceOn
|
55 |
Sweeney, M. C. and Pei, D. (2003) An improved method for rapid sequencing of support-bound peptides by partial edman degradation and mass spectrometry. J. Comb. Chem. 5, 218-222.
DOI
ScienceOn
|
56 |
Synge, R. L. (1945) 'Gramicidin S': over-all chemical characteristics and amino-acid composition. Biochem. J. 39, 363-367.
|
57 |
Tamamura, H., Tsutsumi, H., Masuno, H., Mizokami, S., Hiramatsu, K., Wang, Z., Trent, J. O., Nakashima, H., Yamamoto, N., Peiper, S. C. and Fujii, N. (2006) Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs. Org. Biomol. Chem. 4, 2354-2357.
DOI
ScienceOn
|
58 |
Tamamura, H., Xu, Y., Hattori, T., Zhang, X., Arakaki, R., Kanbara, K., Omagari, A., Otaka, A., Ibuka, T., Yamamoto, N., Nakashima, H. and Fujii, N. (1998) A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. Biochem. Biophys. Res. Commun. 253, 877-882.
DOI
ScienceOn
|
59 |
Tavassoli. A., Benkovic, S. J. (2005) Genetically selected cyclic-peptide inhibitors of AICAR transformylase homodimerization. Angew. Chem. Int. Ed. Engl. 44, 2760-2763.
DOI
ScienceOn
|
60 |
Tavassoli, A., Lu, Q., Gam, J., Pan, H., Benkovic, S. J. and Cohen, S. N. (2008) Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS. Chem. Biol. 3, 757-764.
DOI
ScienceOn
|
61 |
Thakkar. A., Wavreille. A.S. and Pei, D. (2006) Traceless capping agent for peptide sequencing by partial edman degradation and mass spectrometry. Anal. Chem. 78, 5935-5939.
DOI
ScienceOn
|
62 |
Vlieghe, P., Lisowski, V., Martinez, J. and Khrestchatisky, M. (2010) Synthetic therapeutic peptides: science and market. Drug. Discov. Today. 15, 40-56.
DOI
ScienceOn
|
63 |
Wenger, R. M. (1984) Synthesis of cycosporine. Total syntheses of 'cyclosporin A' and 'cyclosporin H', two fungal metabolites isolated from the species. Tolypocladium infl atum GAMS. Helvetica. Chimica. Acta. 67, 502-525.
DOI
|
64 |
Xiao, Q. and Pei, D. (2007) High-throughput synthesis and screening of cyclic peptide antibiotics. J. Med. Chem. 50, 3132-3137.
DOI
ScienceOn
|
65 |
Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature. 415, 389-395.
DOI
ScienceOn
|